Sandra L. Haberichter

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

Paula James, Nathan T. Connell, Barbara Ameer et al. · Blood Advances · 2021 · 492 citations · Full text

Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival

Sandra L. Haberichter, Michael Balistreri, Pamela A. Christopherson et al. · Blood · 2006 · 216 citations · Full text

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

Veronica H. Flood, Joan Cox Gill, Patricia A. Morateck et al. · Blood · 2010 · 180 citations · Full text

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Sandra L. Haberichter, Giancarlo Castaman, Ulrich Budde et al. · Blood · 2008 · 168 citations · Full text

Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment

Helen Yarovoi, Dubravka Kufrin, Don Eslin et al. · Blood · 2003 · 155 citations · Full text